• Gavi's partnership model

in page functions
  • Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector

  • Two key factors set us apart from other actors in global health:

    • The partnership model: as a public-private partnership, we capitalise on the sum of our partners’ comparative advantages;
    • The business model: by pooling demand for vaccines from the world’s poorest countries, securing long-term funding and shaping vaccine markets, we are accelerating access to life-saving vaccines in the countries that need them the most.

    In this section, we explain Gavi’s partnership model and explain the role of each of the Vaccine Alliance’s members.

    Gavi's partnership model

    Credit: UNICEF/Newar.

  • The World Health Organization


    As a founding member of Gavi and the UN's specialist agency on global health issues, WHO is a key Vaccine Alliance partner.



    As the world's biggest buyer and supplier of vaccines for developing countries, UNICEF has a pivotal role in the Vaccine Alliance.

  • The World Bank

    World Bank

    The World Bank brings the expertise of the world's biggest source of development assistance to the Vaccine Alliance.

  • Developing country governments

    Developing Country Governments

    Developing countries are the most important part of the Vaccine Alliance. They apply for support, manage grants and finance immunisation programmes.

  • Civil society organisations


    CSOs help deliver vaccines to remote communities, implement vaccine programmes and advocate for immunisation.

  • Research and technical health institutes

    John Hopkins Hospital

    Partnering with the research community allows Gavi to tap in the latest information and thinking from the scientific, medical and product delivery communities.

  • Every 2 minutes

    One woman dies from cervical cancer every two minutes – or 266,000 a year – over 85% in the developing world. If current trends hold, and without changes in prevention and control, cervical cancer deaths could eventually outpace maternal deaths. HPV vaccines can prevent up to 90% of all cervical cancer cases.


    More facts...

close icon

modal window here